MedTrace Logo

Coroflex® ISAR NEO PMCF Study

NCT05698732 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2026-05-01

No results posted yet for this study

Summary

International, Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Coroflex® ISAR NEO coronary stent system to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Coroflex® ISAR NEO coronary stent system sirolimus eluting stent.

Conditions

  • Coronary Artery Disease (CAD)
  • Ischemic Heart Disease

Interventions

DEVICE

Coroflex® ISAR NEO coronary stent system

Patients in whom treatment with Coroflex® ISAR NEO coronary stent system has been attempted

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-04
Primary Completion
2027-02-01
Completion
2027-02-01

Countries

  • France
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05698732 on ClinicalTrials.gov